Education
About Us
Working with TipRanks
Follow Us
Oncolys BioPharma, Inc. (JP:4588)
:4588
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
4588 Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
¥613
Hold
-0.97%
Downside
Reiterated
07/24/25
Oncolys BioPharma, Inc.'s stock score is primarily impacted by its weak financial performance, with persistent losses and negative cash flows posing significant risks. The technical analysis indicates some short-term bullish potential, but this is overshadowed by poor valuation metrics, including a negative P/E ratio. Investors should be cautious given the company's current financial instability.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
¥613
Hold
-0.97%
Downside
Reiterated
07/24/25
Oncolys BioPharma, Inc.'s stock score is primarily impacted by its weak financial performance, with persistent losses and negative cash flows posing significant risks. The technical analysis indicates some short-term bullish potential, but this is overshadowed by poor valuation metrics, including a negative P/E ratio. Investors should be cautious given the company's current financial instability.
4588 Analyst Recommendation Trends
Rating
May 25
Jul 25
Strong Buy
0
0
Buy
0
0
Hold
1
5
Sell
0
0
Strong Sell
0
0
total
1
5
Each month's total comprises the sum of three months' worth of ratings.
4588 Stock Forecast FAQ
What is JP:4588’s average 12-month price target, according to analysts?
Based on analyst ratings, Oncolys BioPharma, Inc.’s 12-month average price target is 584.00.
What is JP:4588’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for JP:4588, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Oncolys BioPharma, Inc. a Buy, Sell or Hold?
Oncolys BioPharma, Inc. has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Oncolys BioPharma, Inc.’s share price target?
The average share price target for Oncolys BioPharma, Inc. is 584.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ¥584.00 ,and the lowest forecast is ¥584.00. The average share price target represents -5.65% Decrease from the current price of ¥619.
The highest analyst share price target is ¥584.00 ,and the lowest forecast is ¥584.00. The average share price target represents -5.65% Decrease from the current price of ¥619.
What do analysts say about Oncolys BioPharma, Inc.?
Oncolys BioPharma, Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Oncolys BioPharma, Inc.?
To buy shares of JP:4588, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.